Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DPYSL5 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
mRNA | KIF1A | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | SLC26A5 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | KSR2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | RALGDS | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | ADNP2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | RSBN1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | TUBA1A | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
mRNA | KCNC1 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
mRNA | ZNF22 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-09 |